Influence of cytostatics on relative gene expression in redox status, apoptosis and migration colorectal carcinoma model system
-
Published:2023
Issue:45
Volume:
Page:159-177
-
ISSN:1450-9636
-
Container-title:Kragujevac Journal of Science
-
language:en
-
Short-container-title:Kragujevac J Science
Author:
Pavić Jelena, Živanović MarkoORCID, Virijević Katarina, Tanasković IrenaORCID, Stanković VesnaORCID, Marić NebojšaORCID, Cvetković DanijelaORCID, Filipović NenadORCID
Abstract
Colorectal cancer is one of the leading causes of mortality worldwide. It is the most common malignancy and there is a need for new approaches in therapies. Surgery, radiation and chemotherapy are the key components of colon cancer treatment. Besides common chemotherapy, alternative therapies are being studied to increase treatment effectiveness and reduce side effects. In this article, colorectal carcinoma cells were treated with chemotherapeutics and relative gene expression was investigated for the genes coding cytoskeleton proteins: CDH1, CTNNB1 and CDH2; for redox status genes: GPX1, GPX2, GPX3, GPX4, TXNRD1, GSTP1, NFE2L2, NFKB1, HIF1A; and for apoptosis genes: CASP3, CASP8, CASP9, FAS, BCL-2 and BAX. The results of our research showed that some concentrations of chemotherapeutics increased the expression of certain genes. Molecular alterations that lead to colorectal cancer can determine appropriate and effective treatment - chemotherapeutics, as well as the design of direct therapeutic targets.
Funder
Ministry of Education, Science and Technological Development of the Republic of Serbia
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference73 articles.
1. ABDULLAH, M., RANI, A.A., SUDOYO, A.W., MAKMUN, D., HANDJARI, D.R., HERNOWO, B.S. (2013): Expression of NF-kB and COX2 in colorectal cancer among native Indonesians: the role of inflammation in colorectal carcinogenesis. Acta Medica Indonesiana 45 (3): 187-192; 2. ACHARYA, A., DAS, I., CHANDHOK, D., SAHACORRESPONDING, T. (2010): Redox regulation in cancer. Oxidative Medicine and Cellular Longevity 3 (1): 23-34. doi: 10.4161/oxim.3.1.10095; 3. AMETLLER, E., GARCÍA-RECIO, S., COSTAMAGNA, D., MAYORDOMO, C., FERNÁNDEZ-NOGUEIRA, P., CARBÓ, N., PASTOR-ARROYO, E.M., GASCÓN, P., ALMENDRO, V. (2010): Tumor promoting effects of CD95 signaling in chemoresistant cells. Molecular Cancer 9: 161. doi: 10.1186/1476-4598-9-161; 4. ARANGO, D., WILSON, A.J., SHI, Q., CORNER, G.A., ARAÑES, MJ, NICHOLAS, C., LESSER, M., MARIADASON, J.M., AUGENLICHT, L.H. (2004): Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. British Journal of Cancer 91 (11): 1931-19446. doi: 10.1038/sj.bjc.6602215; 5. ASADI, M., SHANEHBANDI, D., KERMANI, T.A., SANAAT, Z., ZAFARI, V., HASHEMZADEH, S. (2018): Expression Level level of caspase genes in colorectal cancer. Asian Pacific Journal of Cancer Preventio, 19 (5): 1277-1280. doi: 10.22034/ APJCP.2018.19.5.1277;
|
|